Streptozocin
In the US, Streptozocin (streptozocin systemic) is a member of the drug class alkylating agents and is used to treat Pancreatic Cancer.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01AD04
CAS registry number (Chemical Abstracts Service)
0018883-66-4
Chemical Formula
C8-H15-N3-O7
Molecular Weight
265
Therapeutic Category
Cytostatic alkylating agent
Chemical Name
D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-
Foreign Names
- Streptozocinum (Latin)
- Streptozocin (German)
- Streptozocine (French)
- Estreptozocina (Spanish)
Generic Names
- Streptozocin (OS: USAN)
- Streptozocine (OS: DCF)
- NRRL 2697 (IS)
- NRRL 3125 (IS)
- Streptozotocin (IS)
- U 9889 (IS: Upjohn)
Brand Names
- Zanosar
CSP, France; IFET, Greece; Pfizer, Canada; Pharmacia, Israel; Teva, United States
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
